University Medical Center Utrecht at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University Medical Center Utrecht takes part in 10 sessions at ESMO 2026 in Madrid. Its program centres on artificial intelligence and real-world data for a learning health system, along with theranostics and antibody-drug conjugates in colorectal cancer. Other sessions cover focused ultrasound for painful bone metastases, shared decision-making in metastatic bladder cancer, and homologous recombination deficiency as a tumour-agnostic target.
| Organization | ESMO 2026 Attendance |
|---|---|
University Medical Center Utrecht Utrecht, Netherlands | |
Academic hospital and faculty of medicine of Utrecht University, in the Netherlands. | Abstract Fri Oct 23 17:20–17:32 Invited Discussant 2072O and LBA55 Melanoma & skin cancers Chair Sat Oct 24 08:30–10:00 Talk Sat Oct 24 08:30–08:50 Chair Sat Oct 24 08:30–10:00 Closing the gap: Promising therapeutic modalities in colorectal cancer Gastrointestinal cancers Talk Sat Oct 24 08:45–09:00 Antibody Drug Conjugates (ADCs): Are we ready for prime time? Gastrointestinal cancers Chair Sat Oct 24 10:15–11:45 Rapid oral 1: Genitourinary tumours, renal and urothelial Genitourinary cancers Talk Sat Oct 24 10:35–10:55 Basic principles of theranostics Sarcoma, CNS, head & neck and rare cancers Abstract Sat Oct 24 11:00–11:15 Invited Discussant 4739RO, 4740RO and 4749RO Genitourinary cancers Chair Sat Oct 24 14:45–16:15 Cutting edge: The evolving role of surgeons in melanoma Melanoma & skin cancers Chair Sat Oct 24 14:45–15:30 Is HRD the next tumour-agnostic target in oncology? Biomarkers & precision oncology Talk Sat Oct 24 17:40–17:50 Abstract Mon Oct 26 09:08–09:18 Talk Tue Oct 27 10:20–10:40 |
Instantly find 20 buyers from University Medical Center Utrecht
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction